Latest Articles
Y&R’s Courtney Hope Shares Personal Battle With Endometriosis - Soap Hub
Y&R’s Courtney Hope Shares Personal Battle With Endometriosis Soap Hub
Published: June 17, 2026, 6:39 p.m.
The UDC collaborates on an intelligent compress to shorten the wait in the diagnosis of endometriosis - Demócrata
The UDC collaborates on an intelligent compress to shorten the wait in the diagnosis of endometriosis Demócrata
Published: June 17, 2026, 4:40 p.m.
Shipley College students collaborate with Endometriosis Awareness North give voice to Women Through New #UNHEARD Campaign - FE News
Shipley College students collaborate with Endometriosis Awareness North give voice to Women Through New #UNHEARD Campaign FE News
Published: June 17, 2026, 3:23 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - First India
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case First India
Published: June 17, 2026, 1:57 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case - outlookbusiness.com
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case outlookbusiness.com
Published: June 17, 2026, 1:44 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - NewsX
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case NewsX
Published: June 17, 2026, 1:06 p.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted
Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times
Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore
Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri
Published: June 17, 2026, 7:01 a.m.
Link copied to clipboard!